Sustained‐Release Naltrexone For Opioid Dependence
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sustained‐Release Naltrexone for Opioid Dependence." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433081/all/Sustained‐Release_Naltrexone_For_Opioid_Dependence.
Sustained‐Release Naltrexone For Opioid Dependence. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433081/all/Sustained‐Release_Naltrexone_For_Opioid_Dependence. Accessed December 30, 2024.
Sustained‐Release Naltrexone For Opioid Dependence. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433081/all/Sustained‐Release_Naltrexone_For_Opioid_Dependence
Sustained‐Release Naltrexone for Opioid Dependence [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433081/all/Sustained‐Release_Naltrexone_For_Opioid_Dependence.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sustained‐Release Naltrexone For Opioid Dependence
ID - 433081
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433081/all/Sustained‐Release_Naltrexone_For_Opioid_Dependence
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -